Invention Grant
US08835438B2 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
有权
治疗精神分裂症引起的记忆力/学习功能障碍的方法与卢卡西酮
- Patent Title: Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
- Patent Title (中): 治疗精神分裂症引起的记忆力/学习功能障碍的方法与卢卡西酮
-
Application No.: US12401958Application Date: 2009-03-11
-
Publication No.: US08835438B2Publication Date: 2014-09-16
- Inventor: Takeo Ishiyama
- Applicant: Takeo Ishiyama
- Applicant Address: JP Osaka
- Assignee: Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee: Sumitomo Dainippon Pharma Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: JP2004-044986 20040220
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/554 ; A61K31/496 ; A61K31/5513 ; A61K31/445 ; G01N33/50 ; C07D417/12
Abstract:
A method of evaluating memory/learning functions with the use of a model with glutamic acid N-methyl-D-aspartate (NMDA) type receptor hypofunction as an animal model for schizophrenia and with the use of reference memory task, wherein there has been found concrete means for detecting any differences in activity between typical anti-psychosis drugs and atypical anti-psychosis drugs is found.An in vivo animal model for screening of a therapeutic agent for improving cognitive dysfunction by schizophrenia is provided.
Public/Granted literature
- US20090176800A1 IN VIVO SCREENING METHOD OF THERAPEUTIC AGENT FOR MEMORY/LEARNING DYSFUNCTIONS BY SCHIZOPHRENIA Public/Granted day:2009-07-09
Information query
IPC分类:
